Yuniar Irene, Hafifah Cut Nurul, Adilla Sharfina Fulki, Shadrina Arifah Nur, Darmawan Anthony Christian, Nasution Kholisah, Ranakusuma Respati W, Safitri Eka Dian
Department of Child Health, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Clinical Epidemiology and Evidence-Based Medicine Unit, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Front Pediatr. 2023 Feb 23;10:1022110. doi: 10.3389/fped.2022.1022110. eCollection 2022.
Several scoring systems are available to assess the severity of sepsis in pediatric patients in diverse settings worldwide. This study investigates the quality and applicability of predictive models for determining pediatric sepsis mortality, especially in acute care and limited-resource settings.
Mortality prediction factors and models were searched in four databases using the following criteria: developed for pediatric health care, especially in acute settings, and with mortality as an outcome.
Two or more reviewers performed the study selection to ensure no bias occurred. Any disagreements were solved by consensus or by the decision of a third reviewer.
The authors extracted the results and mapped the selected studies qualitatively to describe the prognostic properties of the risk factors and models proposed in the study.
The final analysis included 28 mortality prediction models. Their characteristics, analysis, and performance measures were summarized. Performance was described in terms of calibration and discrimination, including assessing for risk of bias and applicability. A modified version of the PRISM-III score based on physiologic criteria (PRISM-III-APS) increased its predictive value to 0.85-0.95. The vasoactive-inotropic score at 12 h had a strong independent association with death. Albumin had an excellent predictive value when combined with other variables. Lactate, a biomarker widely measured in patients with sepsis, was highly associated with mortality. The bioimpedance phase angle was not considered applicable in our setting. Measurement using more straightforward methods, such as mid-upper arm circumference, was feasible in numerous health care facilities.
Leveraging prognostic models to predict mortality among pediatric patients with sepsis remains an important and well-recognized area of study. While much validation and development work remains to be done, available prognostic models could aid clinicians at the bedside of children with sepsis. Furthermore, mortality prediction models are essential and valuable tools for assessing the quality of care provided to critically ill pediatric patients.
在全球不同环境中,有多种评分系统可用于评估儿科患者脓毒症的严重程度。本研究调查了用于确定儿科脓毒症死亡率的预测模型的质量和适用性,特别是在急性护理和资源有限的环境中。
使用以下标准在四个数据库中搜索死亡率预测因素和模型:针对儿科医疗保健开发,特别是在急性环境中,且以死亡率为结果。
由两名或更多评审员进行研究选择,以确保无偏倚。任何分歧通过共识或由第三位评审员决定解决。
作者提取结果并对所选研究进行定性映射,以描述研究中提出的风险因素和模型的预后特性。
最终分析包括28个死亡率预测模型。总结了它们的特征、分析和性能指标。从校准和区分度方面描述性能,包括评估偏倚风险和适用性。基于生理标准的PRISM-III评分的修改版(PRISM-III-APS)将其预测价值提高到了0.85 - 0.95。12小时时的血管活性药物-正性肌力药物评分与死亡有很强的独立关联。白蛋白与其他变量联合使用时具有出色的预测价值。乳酸是脓毒症患者中广泛测量的生物标志物,与死亡率高度相关。生物电阻抗相位角在我们的环境中不被认为适用。使用更直接的方法(如中上臂围)进行测量在许多医疗机构中是可行的。
利用预后模型预测儿科脓毒症患者的死亡率仍然是一个重要且广为人知的研究领域。虽然仍有许多验证和开发工作要做,但现有的预后模型可以帮助床边治疗脓毒症儿童的临床医生。此外,死亡率预测模型是评估危重症儿科患者护理质量的重要且有价值的工具。